Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol.

  • 1 February 1991
    • journal article
    • Vol. 23, 1024-6
Abstract
A combined DST-sequential CyA therapy protocol has been described that results in optimum graft survival for 1- and 2-haplotype mismatched living related donor-recipient combinations. In addition to the excellent graft survival obtained through 4 years, lower prednisone and CyA dosage levels are achieved with significantly decreased infection rates during the posttransplant period.

This publication has 0 references indexed in Scilit: